Ammonia impairs neutrophil phagocytic function in liver disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Hepatology

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/hep.22474PMID 18697192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A.

  2007cited by this paper
• Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome

  2007cited by this paper
• Endotoxemia produces coma and brain swelling in bile duct ligated rats

  2007cited by this paper
• Hyponatremia in cirrhosis: Results of a patient population survey

  2006cited by this paper
• Mechanics of neutrophil phagocytosis: experiments and quantitative models

  2006cited by this paper
• Oxidative Stress and Mitogen-Activated Protein Kinase Phosphorylation Mediate Ammonia-Induced Cell Swelling and Glutamate Uptake Inhibition in Cultured Astrocytes

  2006cited by this paper
• Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.

  2004cited by this paper
• Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

  2004cited by this paper
• Infection and the progression of hepatic encephalopathy in acute liver failure.

  2003cited by this paper
• Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis

  2003cited by this paper
• Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

  2002cited by this paper
• Role of p38MAPK in Cell Volume Regulation of Perfused Rat Liver

  2001cited by this paper
• Glutamine and cell signaling in liver.

  2001cited by this paper
• Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

  2001cited by this paper
• p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability.

  2001cited by this paper
• The systemic inflammatory response syndrome in acute liver failure

  2000cited by this paper
• Hypoosmotic stress activates p38, ERK 1 and 2, and SAPK/JNK in rat hepatocytes.

  2000cited by this paper
• Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients.

  2000cited by this paper
• Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration

  1999cited by this paper
• Involvement of p38MAPK in the regulation of proteolysis by liver cell hydration.

  1999cited by this paper
• Alterations of cell volume regulation in the development of hepatocyte necrosis.

  1999cited by this paper
• Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

  1998cited by this paper
• Helicobacter pylori‐human polymorphonuclear leucocyte interaction in the presence of ammonia

  1997cited by this paper
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

  1995cited by this paper
• A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

  1995cited by this paper
• Organic osmolytes in acute hyponatremia.

  1993cited by this paper
• Interaction of Helicobacter pylori (strain 151) and Campylobacter coli with human peripheral polymorphonuclear granulocytes.

  1993cited by this paper
• Ammonia as a potential mediator of adult human periodontal infection: inhibition of neutrophil function.

  1990cited by this paper
• Effects of ammonia on human neutrophil N-formyl chemotactic peptide receptor-ligand interaction and cytoskeletal association.

  1989cited by this paper
• Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess.

  1987cited by this paper
• Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis

  1986cited by this paper
• Mechanisms of abnormalities in host defences against bacterial infection in liver disease.

  1985cited by this paper
• A simple reliable assay for myeloperoxidase activity in mixed neutrophil-eosinophil cell suspensions: application to detection of myeloperoxidase deficiency.

  1984cited by this paper
• Effects of perfluorochemical on phagocytic function of leukocytes

  1983cited by this paper
• The role of endotoxin in liver injury.

  1975cited by this paper
• Methods in Enzymology

  1968cited by this paper

• Die Darm-Leber-Achse bei Leberzirrhose

  2026cites this paper
• Perfluorooctanoic Acid Exposure Causes Macrophage Ammonia Retention and Induces Spontaneous Miscarriages.

  2026cites this paper
• Network Pharmacology, Molecular Docking, Molecular Dynamics to Explore the Mechanism of Danggui Shaoyao Powder for Hepatic Encephalopathy.

  2025cites this paper
• Patient Plasma-Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis.

  2025cites this paper
• Interaction of inflammation and portal hypertension in cirrhosis progression

  2025cites this paper
• Hyperammonemia induces programmed liver cell death

  2025cites this paper
• Alcoholic cirrhosis-associated immune dysfunction: What does it imply for us?

  2025cites this paper
• Immune Dysfunction and Infection Risk in Advanced Liver Disease.

  2025cites this paper
• Amino Acid Metabolism and Immune Dysfunction in Urea Cycle Disorders: T and B Cell Perspectives

  2025cites this paper
• Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit

  2025cites this paper
• Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin

  2025cites this paper
• The Story of Ammonia in Liver Disease: An Unraveling Continuum.

  2024cites this paper
• Immunopathogenesis of acute on chronic liver failure.

  2024cites this paper
• Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients

  2024cites this paper
• Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers

  2024cites this paper
• The Value of Ammonia as a Biomarker in Patients with Cirrhosis

  2024cites this paper
• Infection, inflammation and hepatic encephalopathy from a clinical perspective

  2024cites this paper
• Ammonia-induced stress response in liver disease progression and hepatic encephalopathy

  2024influential citation
• Liver damage and immune responses

  2024cites this paper
• Tuberculosis in a Liver Cirrhosis Patient: A Management Conundrum

  2024cites this paper
• Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure

  2023cites this paper
• Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis

  2023cites this paper
• Role of ammonia in NAFLD: An unusual suspect

  2023cites this paper
• A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis

  2023cites this paper
• Microbial metabolites in the pathogenesis of periodontal diseases: a narrative review

  2023cites this paper
• Hyperammonemia induced gut microbiota dysbiosis and motor coordination disturbances in mice: new insight into gut‑brain axis involvement in hepatic encephalopathy.

  2023cites this paper
• Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort study

  2023cites this paper
• Circulating neutrophil anti-pathogen dysfunction in cirrhosis

  2023cites this paper
• 784 Burn Injuries During Pregnancy

  2023cites this paper
• Serum ammonia variation predicts mortality in patients with hepatitis B virus-related acute-on-chronic liver failure

  2023cites this paper
• Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

  2023cites this paper
• Ammonia Toxicity and Associated Protein Oxidation: A Single-Cell Surface Enhanced Raman Spectroscopy Study

  2023cites this paper
• Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.

  2022cites this paper
• Asthenia and fatigue in hyperammonemia: etiopathogenesis and methods of correction

  2022cites this paper
• Asthenia and fatigue in hyperammonemia: etiopathogenesis and methods of correction

  2022cites this paper
• The rise and fall and rise again of ammonia as a therapeutic target in HE

  2022cites this paper
• Cost-Effectiveness of Rifaximin-α versus Lactulose for the Treatment of Recurrent Episodes of Overt Hepatic Encephalopathy: A Meta-Analysis

  2022cites this paper
• Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice.

  2022cites this paper
• Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression

  2022cites this paper
• Liver cirrhosis and immune dysfunction.

  2022cites this paper
• Overview of oxidative stress findings in hepatic encephalopathy: From cellular and ammonium-based animal models to human data.

  2022cites this paper
• Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report

  2022cites this paper
• Editorial: infections and hepatic encephalopathy—does the chicken or the egg come first? A novel perspective at the horizon. Authors’ reply

  2022cites this paper
• Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.

  2022cites this paper
• Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation

  2022cites this paper
• Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis

  2022cites this paper
• Dysregulation of murine immune functions on inhalational exposure to ammonia, dimethyl disulfide, 3-methylindole, or propionic acid

  2021cites this paper
• Central nervous system and systemic oxidative stress interplay with inflammation in a bile duct ligation rat model of type C hepatic encephalopathy.

  2021cites this paper
• Potential novel approaches to prevent the risk of infection in patients with variceal bleeding.

  2021cites this paper
• Clostridioides difficile infection in liver cirrhosis patients: A population-based study in United States

  2021cites this paper
• Cirrhosis-associated immune dysfunction

  2021cites this paper
• The gut microbiota in hepatic encephalopathy

  2021cites this paper
• Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

  2021cites this paper
• Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.

  2021cites this paper
• Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts

  2021cites this paper
• Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation

  2021cites this paper
• The multifactorial mechanisms of bacterial infection in decompensated cirrhosis.

  2021cites this paper
• Thioacetamide-induced acute hepatic encephalopathy: central vs peripheral effect of Allicin

  2021cites this paper
• Impact of non-hepatic hyperammonemia on mortality in intensive care unit patients: a retrospective cohort study

  2020cites this paper
• Increasing serum ammonia level is a risk factor for the prognosis of critically ill patients: A multicenter retrospective cohort study.

  2020cites this paper
• Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease

  2020influential citation
• Hyperammonemia in azotemic cats

  2020cites this paper
• Neutrophilia is associated with a poorer clinical outcome in dogs with chronic hepatitis

  2020cites this paper
• Albumin in decompensated cirrhosis: new concepts and perspectives

  2020cites this paper
• Comparative eco-physiology revealed extensive enzymatic curtailment, lipases production and strong conidial resilience of the bat pathogenic fungus Pseudogymnoascus destructans

  2020cites this paper
• Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute‐on‐chronic liver failure

  2020cites this paper
• Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.

  2020cites this paper
• Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease

  2020cites this paper
• The innate immune cells in cirrhosis.

  2020cites this paper
• Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.

  2020cites this paper
• Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

  2019cites this paper
• Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans

  2019cites this paper
• Acute-on-chronic liver failure in patients with alcohol-related liver disease.

  2019cites this paper
• Prognostic Role of Ammonia in Cirrhotic Patients

  2019cites this paper
• Growing muscle against cirrhosis: In the quest for models to revealing mechanisms

  2019cites this paper
• Dysfunctional Immune Response in Acute-on-Chronic Liver Failure: It Takes Two to Tango

  2019cites this paper
• Effect of hepatitis C virus infection on patients with pulmonary tuberculosis

  2019cites this paper
• Prognostic Role of Ammonia in Patients With Cirrhosis

  2019cites this paper
• Altered Microbiome in Patients With Cirrhosis and Complications

  2019cites this paper
• Acute-on-Chronic Liver Failure in Patients with Alcoholic Liver Disease

  2019cites this paper
• Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice

  2018cites this paper
• Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.

  2018cites this paper
• Hepatic Encephalopathy in Patients in Lviv (Ukraine)

  2018cites this paper
• Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis.

  2018cites this paper
• Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.

  2018cites this paper
• Platelet‐leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion

  2018cites this paper
• Predictors of infection in viral-hepatitis related acute liver failure

  2017cites this paper
• Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic rats

  2017cites this paper
• Hepatic Encephalopathy.

  2017cites this paper
• DysfunctionDrives Dendritic Cells into

  2017cites this paper
• Commiphora molmol Modulates Glutamate-Nitric Oxide-cGMP and Nrf2/ARE/HO-1 Pathways and Attenuates Oxidative Stress and Hematological Alterations in Hyperammonemic Rats

  2017cites this paper
• Role of ammonium ions on the modulation of apoptosis in glutamine-starved cells

  2017cites this paper
• Health care-associated infections in pre-transplant liver intensive care unit: Perspectives and challenges.

  2017cites this paper
• Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis

  2016cites this paper
• Ammonia toxicity: from head to toe?

  2016cites this paper
• High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.

  2016cites this paper
• Hepatic encephalopathy in dogs and cats.

  2016cites this paper
• Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

  2016cites this paper
• Bacterial infections in cirrhosis: A critical review and practical guidance.

  2016cites this paper
• Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.

  2016cites this paper